PharmiWeb.com - Global Pharma News & Resources
19-Jun-2023

Cannovum Cannabis AG : Cannovum Cannabis AG: Full focus on the legalization of cannabis and change in management

EQS-News: Cannovum Cannabis AG / Key word(s): Strategic Company Decision/Personnel
Cannovum Cannabis AG : Cannovum Cannabis AG: Full focus on the legalization of cannabis and change in management
19.06.2023 / 15:04 CET/CEST
The issuer is solely responsible for the content of this announcement.

Cannovum Cannabis AG: Full focus on the legalization of cannabis and change in management

 

Cannovum Cannabis AG (stock exchanges Frankfurt, Xetra, Düsseldorf, Munich, Hamburg, Berlin, Tradegate, gettex: ISIN DE000A2LQU21), one of the leading German cannabis companies traded on the stock exchange, is fully focused on the upcoming legalization of cannabis in Germany. Already, Cannovum Cannabis AG and the Anbau Allianz für Deutschland it co-founded is the partner for politicians, cultivators and the forming cannabis clubs throughout Germany.

 

As part of this strategic decision, Cannovum Cannabis AG will outsource its existing successful medical business. This will be done under the leadership of founder and board member Pia Marten as part of a management buy-out. Cannovum Cannabis AG continues to hold 25 percent of the company responsible for the medical business, Cannovum Health eG. With the management buy-out, Pia Marten leaves the Management Board of Cannovum Cannabis AG. From now on, the management of Cannovum Cannabis AG is in the hands of the sole CEO Klaus Madzia.

 

Klaus Madzia: "The legalization of cannabis in Germany is imminent. We see a unique opportunity in this billion-dollar market and are concentrating our forces. The cultivation alliance for Germany founded by Cannovum Cannabis is already the pacesetter for legalization."

 

Pia Marten: "Cannovum Health eG will focus on the already regulated medical cannabis market. Through new capital brought into the company, we will focus on accelerating the growth of Cannovum Health eG. Especially with the focus on extract distribution we aim for sustainable profitability. I wish Cannovum Cannabis AG under the leadership of Klaus Madzia much success and thank you for the good cooperation."

 

Contact:

Klaus Madzia

Board of Directors

Cannovum Cannabis AG

Phone: +49 30 3982 163 62

E-mail: klaus.madzia@cannovum.com

 

Cannovum Cannabis AG is the first German fully licensed cannabis company traded on the stock exchange. The shares are traded on the Frankfurt, Xetra, Düsseldorf, Munich, Berlin, Hamburg and gettex stock exchanges. Cannovum Cannabis AG is ready for the legalization of cannabis and well-prepared for this billion dollar market.

 

 

 



19.06.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Cannovum Cannabis AG
Rheinsberger Str. 76/77
10115 Berlin
Germany
Phone: +49 (0)30 3982 16360
E-mail: klaus.madzia@cannovum.com
Internet: www.cannovum.com
ISIN: DE000A2LQU21
WKN: A2LQU2
Listed: Regulated Unofficial Market in Berlin, Dusseldorf (Primärmarkt), Frankfurt, Hamburg, Munich, Tradegate Exchange
EQS News ID: 1660551

 
End of News EQS News Service

Editor Details

Last Updated: 19-Jun-2023